241 related articles for article (PubMed ID: 32711050)
1. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
Sato Y; Rahman MM; Haneda M; Tsuyama T; Mizumoto T; Yoshizawa T; Kitamura T; Gonzalez FJ; Yamamura KI; Yamagata K
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165898. PubMed ID: 32711050
[TBL] [Abstract][Full Text] [Related]
2. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
[TBL] [Abstract][Full Text] [Related]
3. Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet.
Mühlemann M; Zdzieblo D; Friedrich A; Berger C; Otto C; Walles H; Koepsell H; Metzger M
Mol Metab; 2018 Jul; 13():67-76. PubMed ID: 29859847
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells.
Solini A; Sebastiani G; Nigi L; Santini E; Rossi C; Dotta F
Diabetes Metab; 2017 Dec; 43(6):512-520. PubMed ID: 28499695
[TBL] [Abstract][Full Text] [Related]
5. No direct effect of SGLT2 activity on glucagon secretion.
Kuhre RE; Ghiasi SM; Adriaenssens AE; Wewer Albrechtsen NJ; Andersen DB; Aivazidis A; Chen L; Mandrup-Poulsen T; Ørskov C; Gribble FM; Reimann F; Wierup N; Tyrberg B; Holst JJ
Diabetologia; 2019 Jun; 62(6):1011-1023. PubMed ID: 30903205
[TBL] [Abstract][Full Text] [Related]
6. Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.
Servitja JM; Pignatelli M; Maestro MA; Cardalda C; Boj SF; Lozano J; Blanco E; Lafuente A; McCarthy MI; Sumoy L; Guigó R; Ferrer J
Mol Cell Biol; 2009 Jun; 29(11):2945-59. PubMed ID: 19289501
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor HNF1α induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs.
Pedersen KB; Chhabra KH; Nguyen VK; Xia H; Lazartigues E
Biochim Biophys Acta; 2013 Nov; 1829(11):1225-35. PubMed ID: 24100303
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin Inhibition Restores Glucose Homeostasis in Hepatocyte Nuclear Factor-1α (MODY3)-Deficient Mice.
Brial F; Lussier CR; Belleville K; Sarret P; Boudreau F
Diabetes; 2015 Sep; 64(9):3314-20. PubMed ID: 25979074
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Bonner C; Kerr-Conte J; Gmyr V; Queniat G; Moerman E; Thévenet J; Beaucamps C; Delalleau N; Popescu I; Malaisse WJ; Sener A; Deprez B; Abderrahmani A; Staels B; Pattou F
Nat Med; 2015 May; 21(5):512-7. PubMed ID: 25894829
[TBL] [Abstract][Full Text] [Related]
10. SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans.
Chae H; Augustin R; Gatineau E; Mayoux E; Bensellam M; Antoine N; Khattab F; Lai BK; Brusa D; Stierstorfer B; Klein H; Singh B; Ruiz L; Pieper M; Mark M; Herrera PL; Gribble FM; Reimann F; Wojtusciszyn A; Broca C; Rita N; Piemonti L; Gilon P
Mol Metab; 2020 Dec; 42():101071. PubMed ID: 32896668
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP kinase I modulates glucagon release from pancreatic α-cells.
Leiss V; Friebe A; Welling A; Hofmann F; Lukowski R
Diabetes; 2011 Jan; 60(1):148-56. PubMed ID: 20978093
[TBL] [Abstract][Full Text] [Related]
12. HNF1α maintains pancreatic α and β cell functions in primary human islets.
Qian MF; Bevacqua RJ; Coykendall VM; Liu X; Zhao W; Chang CA; Gu X; Dai XQ; MacDonald PE; Kim SK
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37943614
[TBL] [Abstract][Full Text] [Related]
13. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
14. Tubular proteinuria in patients with HNF1α mutations: HNF1α drives endocytosis in the proximal tubule.
Terryn S; Tanaka K; Lengelé JP; Olinger E; Dubois-Laforgue D; Garbay S; Kozyraki R; Van Der Smissen P; Christensen EI; Courtoy PJ; Bellanné-Chantelot C; Timsit J; Pontoglio M; Devuyst O
Kidney Int; 2016 May; 89(5):1075-1089. PubMed ID: 27083284
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells.
Miura A; Yamagata K; Kakei M; Hatakeyama H; Takahashi N; Fukui K; Nammo T; Yoneda K; Inoue Y; Sladek FM; Magnuson MA; Kasai H; Miyagawa J; Gonzalez FJ; Shimomura I
J Biol Chem; 2006 Feb; 281(8):5246-57. PubMed ID: 16377800
[TBL] [Abstract][Full Text] [Related]
16. Roles of HNF1α and HNF4α in pancreatic β-cells: lessons from a monogenic form of diabetes (MODY).
Yamagata K
Vitam Horm; 2014; 95():407-23. PubMed ID: 24559927
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes.
Yamagata K; Nammo T; Moriwaki M; Ihara A; Iizuka K; Yang Q; Satoh T; Li M; Uenaka R; Okita K; Iwahashi H; Zhu Q; Cao Y; Imagawa A; Tochino Y; Hanafusa T; Miyagawa J; Matsuzawa Y
Diabetes; 2002 Jan; 51(1):114-23. PubMed ID: 11756330
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction contributes to impaired insulin secretion in INS-1 cells with dominant-negative mutations of HNF-1alpha and in HNF-1alpha-deficient islets.
Pongratz RL; Kibbey RG; Kirkpatrick CL; Zhao X; Pontoglio M; Yaniv M; Wollheim CB; Shulman GI; Cline GW
J Biol Chem; 2009 Jun; 284(25):16808-16821. PubMed ID: 19376774
[TBL] [Abstract][Full Text] [Related]
19. Defining the transcriptional regulation of the intestinal sodium-glucose cotransporter using RNA-interference mediated gene silencing.
Balakrishnan A; Stearns AT; Rhoads DB; Ashley SW; Tavakkolizadeh A
Surgery; 2008 Aug; 144(2):168-73. PubMed ID: 18656622
[TBL] [Abstract][Full Text] [Related]
20. Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic α-cell.
Salvatori AS; Elrick MM; Samson WK; Corbett JA; Yosten GL
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1257-63. PubMed ID: 24735892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
